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Abstract 
We investigated an effect of end-stage renal disease (ESRD) on the visual system by 
measuring the ability of 21 patients to perceive depth in the random dot stereograms and 
circles of the Randot Test. To control for other factors which might influence performance on 
the tests of stereopsis, patients were compared with healthy controls matched for age, years of 
education, IQ, and general cognitive ability. Vernier acuity (thought to reflect mainly central 
processing) and Landolt acuity (more sensitive to retinal and optical abnormalities) were also 
measured, but the study did not include a formal ophthalmological examination. All controls 
could perceive depth in random dot stereograms, whereas 9/21 patients could not. Patients 
who could perceive depth had worse stereoacuity than did their matched controls. The patient 
group as a whole had worse Vernier and Landolt acuities than the controls.  The stereoblind 
patient subgroup had similar Vernier acuity to the stereoscopic subgroup, but worse Landolt 
acuity, and were more likely to have peripheral vascular disease. We conclude that ESRD had 
affected structures both within the eye, and within the visual brain. However, the similarity of 
Vernier acuity and difference of Landolt acuity in the stereoblind and stereoscopic patient 
subgroups suggest that the differences in stereoscopic ability arise from abnormalities in the 
eyes rather than in the brain. 
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Introduction 
In end-stage renal disease (ESRD), failure of the kidneys leads to changes in the quality of the 
blood supply to the central nervous system. A variety of cognitive changes has been reported 
in the illness, including impairments of memory and attention.1-2 One might expect that 
effects of ESRD on the visual brain would produce similar impairments in visual processing, 
but almost no studies appear to have investigated this. A possible exception is the study by 
Chiu et al3 in which established haemodialysis (HD) patients were tested on their stereoscopic 
depth perception, an ability which requires combination in the brain of information from each 
eye, and which was found to be impaired in many patients.  In some chronic illnesses, 
possible evidence for central impairment of stereopsis has come from imaging studies.  
Patients with Parkinson’s disease who lack stereopsis have reduced grey matter volume in 
right extrastriate visual cortex compared with patients with stereopsis.4 In Alzheimer’s 
disease, maximum responses to stereomotion, as measured with fMRI, occur in different brain 
regions to those in control participants.5 Although it is not clear whether these central effects 
are the cause or an effect of the changes in stereopsis, changes to visual cortex in ESRD may 
underlie losses of stereopsis found by Chiu et al. However, there are some problems of 
interpretation of the results of that study. 
1. In the Chiu et al study, participants attempted three parts of the Titmus test, in which 
they inspected a series of images while wearing polaroid spectacles. In the Housefly 
sub-test, one is required to touch the wing of a 3-D image of an insect, which after 
stereoscopic fusion appears above the page on which the two oppositely polarized views 
are printed. In the Animals subtest, one identifies which of a row of animals is 
protruding. In the Dots sub-test, one identifies which of four dots forming a cross is 
protruding. In successive images, the binocular disparity of the protruding dot is 
gradually decreased, allowing a quantitative measure of stereoacuity. About 30% of the 
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157 patients tested by Chiu et al3 failed the Housefly sub-test, and about 58% and 64% 
of those who subsequently attempted the largest disparity versions of the Animals and 
Dots sub-tests, respectively, failed. A feature of the Titmus test is that the shapes to be 
seen after binocular combination are also visible in each monocular image.  This means 
that, even when the half-images cannot be stereoscopically fused, the viewer might have 
some information about the likely position in 3D space of the feature, as found for 
stereoscopic images outside Panum’s limit by Westheimer and Tanzman.12 Another 
possibility is that visual mechanisms controlling the manual response in the Housefly 
sub-test might be abnormal, even when those processing the stereogram were 
functioning normally (though this criticism would not apply to the Animals and the Dots 
sub-tests).  Thus the Titmus test may not give an accurate estimate of losses of stereopsis 
in ESRD. 
2. It is possible that impairment of stereopsis in ESRD results from changes within the eyes 
rather than in the brain. Ocular abnormalities are common in ESRD, and are often 
associated with HD. These can include band keratopathy, cataract, macular oedema, 
retinal haemorrhage and detachment, and optic neuropathy.6 The occurrence and nature 
of another putative symptom (change in intra-ocular pressure) has been questioned, but 
may be found in some susceptible patients.7 Not surprisingly, these anatomical and 
physiological changes have been associated with various functional losses in ESRD. 
Luminance thresholds are raised,8 visual fields restricted,9 and visual acuity and contrast 
sensitivity reduced.3 It is possible that dialysis may contribute to some of these losses. 
For example, Tomazzoli et al10 found reduced visual acuity after dialysis, which could 
be alleviated with appropriate optical correction, and which they attributed to 
dehydration of the lens. Since stereoacuity can be impaired by e.g. image blur11, it is 
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possible that losses of stereopsis in ESRD could be caused by ocular dysfunction of 
some kind. 
3. Chiu et al report that failure on the Housefly test was associated with a low MMSE score 
and more advanced age, and that many patients refused further testing on the Animals 
and Dots tests for reasons which included fatigue. Their patients, many of whom may 
have been frail and cognitively impaired, were compared with published norms, 
obtained presumably from healthy individuals, so that it is not clear to what extent these 
other factors may have contributed to their test performance.   
 
We aimed to address these potential difficulties of interpretation as follows.  
1. Stereopsis was assessed with two subtests of the Randot Stereotest, namely the Forms 
and the Circles.  The former consists of two arrays of four random dot stereograms, in 
which easily named shapes (e.g. circle, triangle, the capital letter E) are seen if 
stereopsis is present.  In one array, the binocular disparity of the elements depicting the 
shape is 500 sec, and in the other 250 sec, at the recommended viewing distance of 40 
cm for the booklet in which the tests are printed. In each array, one of the stereograms 
contains no shape, as a check against guessing.  In the Circles test, the viewer inspects 
rows of three circles, one of which protrudes in front of the other two. The disparity of 
the protruding circle, which is 400 sec on the first row, reduces on successive rows to 
be 20 sec on the 10th and last row, allowing a quantitative measure of stereoacuity. 
Thus the Randot Circles sub-test is comparable to the Titmus Dots sub-test.  Unlike the 
Housefly sub-test, however, the Forms sub-test contains no visible monocular clues to 
the binocularly visible shape, and does not require a precise manual response.  
2. With the aim of assessing the relative contribution of retinal and cortical factors in 
visual losses in ESRD, we carried out two tests of visual acuity from the Freiburg 
6 
 
Visual Acuity and Vision Test (FrACT) package13: the Landolt C and the Vernier 
Acuity tests. Chiu et al3 assessed acuity in their patients with the Lighthouse Near 
Visual Acuity Test (a chart with letters of progressively decreasing size) and found 
that about 96% had acuities in the better eye which were worse than the published 
population norms. The Landolt is sensitive to optical and retinal degradation because it 
measures spatial resolution, the ability to detect tiny gaps in visual stimuli. We also 
measured Vernier acuity because the ability to detect an offset between two extended 
bars is thought to be less dependent on optical and retinal abnormalities and so is more 
likely to reflect cortical dysfunction.  Vernier acuity is finer than the diameter of 
photoreceptors, and so must depend on processes later in the visual system11.  That its 
limit is set by cortical processes is suggested by the finding that, with eccentric 
viewing, Vernier acuity scales with the cortical magnification factor, unlike spatial 
resolution14, which is measured by the Landolt C test. 
3. Instead of comparing patients with published performance norms, we matched patients 
with controls of similar age and abilities. In addition to the primary tasks, all 
participants completed the Mini Mental State Examination (MMSE),15 an assessment 
of general cognitive ability, the Instrumental Activities of Daily Living scale (IADL),16 
the National Adult Reading Test (NART),17 from which pre-morbid IQ can be 
estimated, and the Geriatric Depression Scale (GDS).18 
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Methods 
Participants 
Approval for the study was given by the University Research Ethics Committee and the local 
National Research Ethics Service (NRES). Twenty-one patients, ranging from 37 to 88 years 
of age (mean age: 67.7, SD: 14.45) were recruited from the renal unit at the Royal Berkshire 
Hospital (RBH) in Reading, Berkshire, UK. These ESRD patients received HD three times 
per week for 3 to 5 hours per treatment and had been receiving HD treatment for a minimum 
of 90 days prior to testing, with a Kt/v > 1.4 (dialysis adequacy).  Informed consent was 
obtained by a nephrologist independent of the study. Details of comorbid conditions and 
other relevant history were obtained from medical records. Patients were excluded from the 
study if they had any prior history of ophthalmological or neurological illness. Thus, three 
potential participants were excluded: one was blind in one eye, the second had had surgical 
correction of a squint, and the third had had a retinal detachment. It is possible that some of 
the patients and controls who were tested had other visual problems of which they were 
unaware or unwilling to report. Testing was conducted in a quiet office in the RBH. 
Twenty-one healthy control participants (mean age: 67.3 years, SD: 14.2) were recruited 
from a research volunteer panel maintained by the Department of Psychology at the 
University of Reading. Potential participants were excluded if they had a history of renal, 
ophthalmological, or neurological illness. Thus, one was excluded because they reported very 
poor vision in one eye, from a young age. Control participants were individually matched to 
the patients for age, sex, and education level. They were tested in a quiet room within the 
Department of Psychology, after informed consent had been obtained, and were reimbursed 
for their travelling expenses. 
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Each patient was tested immediately before a dialysis session (and so at least two days since 
the previous dialysis). Their matched control was tested at approximately the same time of 
day. 
Test Materials and Procedure  
Visual tests 
Both testing rooms were lit by conventional fluorescent lighting of about 500 lux. Thus all 
stimuli were viewed in conditions which were comfortably within the photopic range.  
FrACT stimuli were presented on a Toshiba 17.3” LCD screen laptop computer, and viewed 
binocularly. The participant was seated in a comfortable chair, at a viewing distance of 
180cm from the screen. In the Landolt C test, a series of 24 presentations was made, in each 
of which the gap in a circle can be in one of 8 positions. If the participant correctly identifies 
the location of the gap it is reduced on the next presentation, or, if an error is made, it is 
maintained or reduced on the next presentation, according to an adaptive staircase procedure 
which homes in on a chosen level of performance (62.5% at a 25% guessing rate). On the 
initial presentation, the outer diameter of the C was 48 min arc, and the gaps width was 9.5 
min arc. In the Vernier acuity task, a series of 42 vertical Verniers is presented, with the 
lower line offset to the right or left of the upper line, and the participant judges the direction 
of the offset. Each bar of the Vernier stimulus was 14 arc min long x 2 arc min wide. The 
initial offset was 2 arc min. As in the Landolt C procedure, the offset is varied according to 
the participant’s performance on successive presentations, until some criterion level of 
performance is reached. 
For the Randot tests, which followed the acuity tests, the seated participant wore polaroid 
spectacles and held the booklet at a distance of aproximately 40 cm. The nature of the two 
subtests is described above in a comparison with the sub-tests of the Titmus test. For the 
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Forms test, the participant was required to point to and describe the shapes in each array of 
stereograms, first those with 500 sec disparity, then those with 250 sec disparity. Following 
this, they were required to identify the location of the protruding circle in the Circles test, 
beginning with the largest disparity. Stereoacuity was taken to be the disparity before the 
stimulus at which the participant made an error or reported that they could not differentiate 
between the depths of the three circles. In the latter case, they were not forced to guess. 
Participants wore their usual optical correction for the viewing distances in the visual tests. 
Neuropsychological tests 
Mini Mental State Exam (MMSE) 
The MMSE15 is a short questionnaire designed to screen for cognitive impairment. The 30 
questions assess memory, orientation to time, orientation to place, attention and language. A 
score of 25-30 indicates normal cognition, 21-24 mild, 10-20 moderate and <9 severe 
impairment.  
National Adult Reading Test (NART) 
The NART16 assesses pre-morbid intelligence in English-speaking individuals. Fifty words, 
whose reading difficulty varies, are shown on a single sheet, and have to be read aloud.  
Overall, verbal and performance IQ can be estimated from the number of words correctly 
pronounced. 
Instrumental Activities of Daily Living scale (IADL) 
The IADL17 assesses an individual’s independence and how they deal with the demands of 
everyday life. Eight different domains are assessed, including food preparation, driving, and 
shopping; the scale ranges from 0 (low independence) to 8 (full independence). 
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Geriatric Depression Scale (GDS) 
The GDS18 is a 15-item screening tool for depression in the elderly. It is short and easy to 
administer using a number of questions about mood and anxiety to estimate a score of 
depression. A score of 0-4 is considered normal, 5-9 is mild depression and 10-15 is more 
severe depression. 
 
Results 
Demographic and medical information 
Some characteristics of the patient and control groups are shown in Table 1. It may be seen 
that the groups were well matched for age, years of education, overall (pre-morbid) IQ 
(NART) and general cognitive ability (MMSE). From their GDS scores, the patients showed 
significantly more signs of depression than the controls, though as a group their symptoms 
were mild (a score of 4 or less is considered normal).  The patients were also mildly impaired 
in activities of daily living (the maximum score, achieved by all controls, is 8). Table 2 shows 
some medical characteristics of the patient group, including duration of dialysis, cause of 
ESRD, and co-morbidities.  
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Table 1. Demographic information for patient and control groups.  
NART = National Adult Reading Test, GDS = Geriatric Depression Scale, MMSE = Mini Mental 
State Examination, IADL = Instrumental Activities of Daily Living. M / F = Male / Female.  
 
 
 
 
 
 
 
 
 
                         Group   
Patient (N = 21) Control (N = 21)   
Mean SD Mean SD   t  p-value 
Age (yr.) 67.7 14.5 67.3 14.2 0.099 0.921 
Education (yr.) 11.9 2.7 12.2 2.6 -0.353 0.726 
NART Overall IQ 109.4 25.9 111.2 26.9 -0.219 0.828 
GDS 4.2 3.3 1.8 1.5 2.897 .006 
MMSE 27.7 2.1 28.5 1.0 -1.545 .131 
IADL 6.6 1.5 8.0 0.0 -3.924 <.001 
M / F 13 / 8 - 13 / 8 - - - 
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Table 2. Medical characteristics of ESRD patients.  
 
               HD Patients (n = 21) 
Characteristic No. of Patients Percentage  
Age (yr.)   
<55 4 19.1 
55-64 5 23.8 
65-74 3 14.3 
75-85 8 38.1 
>85 1 4.8 
   
Dialysis Duration (months)   
0-12 3 14.3 
13-24 5 23.8 
>24 13 61.9 
   
Cause of ESRD   
Type 2 diabetes mellitus 
 
3 14.3 
Type 1 diabetes mellitus 1 4.8 
Adult polycystic kidney disease 2 9.5 
Chronic kidney disease (unknown cause) 4 19.0 
Obstructive uropathy 2 9.5 
Glomerulonephritis 
 
 
5 23.8 
Vasculitis 2 9.5 
Hypertensive/renovascular disease 1 4.8 
Surgical loss 1 4.8 
 
 
Comorbid Conditions   
Peripheral vascular disease 7 33.3 
Diabetes 7 33.3 
Hypertension 15 71.4 
Stroke 3 14.3 
Myocardial infarction 1 4.8 
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Vernier and Landolt acuities 
Mean Landolt and Vernier acuities in the patient and control groups are shown in Figure 1.  
Independent t-tests revealed that patients had significantly lower acuity than controls on the 
Landolt C test (t(39) = 3.399, p = 0.002), and also (after log transformation of the scores to 
equate the variances) on the Vernier task (t(37) = 3.037, p = .004). Due to testing fatigue, one 
control did not complete the Landolt task, and two patients and one control did not complete 
the Vernier test. 
 
 
Figure 1. Mean Landolt C and Vernier acuities for the ESRD and control groups. Error bars 
= ±1 S.E. 
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Stereopsis 
9 of the 21 patients (42.9%) could not perceive the figures in the Randot Forms subtest, 
whereas all the controls could do so (a difference which was significant (Fisher’s Exact p = 
0.0007)). None of these 9 patients could perform the Circles test, even at the largest disparity.  
The mean stereoacuity from the Circles tests of the 12 patients who could identify the figures 
in the Forms test was 139.17 sec arc (SE = 39.68), that of their matched controls 53.33 sec 
arc (SE=15.8). This difference was significant (t(22) = 2.124, p= 0.045, after log 
transformation of the scores to equate the variances).  
Figure 2 shows Landolt and Vernier acuities for the stereoblind and stereoscopic sub-groups 
of patients.  Landolt acuity was worse in the stereoblind group, with the difference from  
 
Figure 2. Mean visual acuities in stereoblind patients with ESRD and those with stereopsis. 
Error bars = ±1 S.E. 
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the stereoscopic subgroups approaching significance on a parametric test (t(19) =1.732, p= 
0.09). On a test of medians, the sub-groups were significantly different (Fisher’s Exact 
p=0.03).  Vernier acuities were almost identical in the two sub-groups, and the difference 
between them was not significant, either with a parametric (t(19) =0.144, p= 0.89) or a non-
parametric test (Fisher’s Exact p=0.99).   
Other characteristics of the stereoblind and stereoscopic subgroup are shown in Table 3. 
None of the differences in years of education, or of scores on the NART, GDS, MMSE or 
IADL were significant on a parametric test,  nor on a comparison of medians for the smallest 
differences (Fisher’s Exact p for age = 0.09, for duration of dialysis = 0.67, for years of 
education = 0.99, and for IADL = 0.08). Although the stereoblind group tended to be older, 
and to have spent more time on dialysis, the differences between the groups were not 
significant. There were no significant differences between the groups in the incidence of 
hypertension, stroke, myocardial infarction or diabetes (though it is possible that the two 
diabetics in the stereoblind group had undiagnosed retinopathy). However, peripheral 
vascular disease was significantly more common in the stereoblind group (55.5%) than in the 
stereoscopic group (8.3%) – Fisher’s Exact p = 0.046. 
Correlations 
In the control group, none of the correlations between the three tests of acuity was significant 
(largest r=0.312, smallest p= 0.18, n=21).  The only significant correlation between an acuity 
and a demographic or neuropsychological measure was between Landolt acuity and age 
(r=0.655, p= 0.002, n=21); older people having worse acuity. 
The correlation between Landolt and Vernier acuities in the patients did not reach 
significance (r=0.375, p=0.094; n=19).  Landolt acuity in patients correlated significantly 
with age (r=0.642, p=0.002, n=20 – older people were worse). Both acuities correlated 
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significantly with activities of daily living (Landolt: r=-0.497, p= 0.022, n=20; Vernier: r=-
0.452, p= 0.040, n=19): in both cases, worse acuity was associated with greater impairment in 
tasks of everyday living. In the patients with stereopsis, stereoacuity correlated positively and 
significantly with Landolt acuity (r=0.698, p= 0.012; n=12), but not with Vernier acuity 
(r=0.351, p= 0.264). Patient stereoacuity did not correlate with age or years of education, or 
with scores on the NART, GDS, MMSE or IADL (largest r=0.542, smallest p= 0.069, n=12). 
 
Table 3. Characteristics of ESRD stereoblind and stereoscopic groups 
 
  
 
                         Group   
Stereoblind (N = 9) Stereo (N = 12)   
Mean SD Mean SD   t  p-value 
Age (yr.) 72.7 14.0 64.0 14.2 1.392 0.180 
Dialysis duration (mo) 53.3 57.2 33.4 19.1 1.42 0.171 
Education (yr.) 10.7 1.7 12.8 3.1 -1.82 0.085 
NART Overall IQ 109.4 25.9 111.2 26.9 -0.219 0.828 
GDS 4.3 2.8 4.1 3.8 0.167 0.889 
MMSE 27.7 2.3 27.7 1.9 -0.000 1 
IADL 6.3 1.2 6.8 1.7 -0.731 0.473 
M / F 5 / 4 - 7 / 5 - - - 
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Discussion 
In all three tests of acuity, ESRD patients performed worse than controls. Thus, our findings 
with the Landolt C and Randot tests confirm those of Chiu et al3 with the Lighthouse Near 
Acuity chart and the Titmus test. As our patients were matched with healthy controls for age, 
IQ and general cognitive ability, we can be more confident that our findings reflect a visual 
loss rather than some other difficulty in carrying out the tests. 
A striking feature of the data was the lack of any measurable stereoscopic ability in more than 
40% of our patients. That this occurred with random dot stereograms, in the absence of 
monocular cues, suggests a genuine difficulty in binocular combination. The remaining 
patients, who could perceive depth in random dot stereograms, nevertheless had worse 
stereoacuity than did their matched controls.  The stereoblind and stereoscopic ESRD sub-
groups could not be distinguished on any of our demographic or neuropsychological 
measures (see Table 3). The only significant difference in co-morbidity was a significantly 
higher incidence of peripheral vascular disease in the stereoblind group. The two groups had 
almost identical Vernier acuity. The only other apparent distinguishing feature was a 
difference in their Landolt acuity (see Figure 2).  
What do the results tell us about the effects of ESRD on the visual system? The worse 
Vernier acuity in the patient group as a whole suggests some impairment in cortical 
processing, perhaps a reduction in orientation discrimination19. However, the similar 
performance of the stereoblind and stereoscopic subgroups on the Vernier acuity test suggests 
a similarity in at least one aspect of cortical processing, despite the differences in binocular 
combination. In contrast, our data from the Landolt test, showing greater impairment in the 
stereoblind subgroup, appear to be consistent with differences within the eyeball, either 
optical or retinal, between the two patient subgroups.  For example, Quaid et al20 showed that 
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blurring with positive lenses or with contact lenses which simulate cataracts had a greater 
effect on letter than on Vernier acuity. In their study, blurring had little effect on Vernier 
acuity below two dioptres. Blurring impairs the perception of random dot stereograms21 and 
stereoacuity.22  The effects of contrast reduction are greater on stereoacuity than on Vernier 
acuity.20  Thus the differences we found between the stereoblind and stereoscopic subgroups 
could result from some optical degradation (perhaps refractive error, cataract, and/or deposits 
in the cornea) which was large enough to produce a differential effect on Landolt acuity and 
stereoacuity, but not large enough to affect Vernier acuity differentially.  This notion is also 
supported by the correlation between Landolt acuity and stereoacuity in the stereoscopic 
patient subgroup. Although uncorrected refractive error is not uncommon in older people (see 
studies summarised by Shickle and Griffin23), it seems unlikely that this alone could account 
for the differences between the patient and control groups in our study. For example, any 
effects on refraction through dehydration of the lens caused by dialysis in the patient group 
(as found by Tomazzoli et al,10) would have dissipated after two days, and one might expect 
any residual refractive errors to be spread equally over the patient and control groups. 
It is also possible that there might be additional differences in retinal processing between the 
patient subgroups; of the four diabetic patients, two had stereopsis and two were stereoblind. 
It is possible that the latter two patients had diabetic retinopathy, though this was not 
mentioned in their medical records. The stereoblind subgroup had a higher incidence of 
peripheral vascular disease, which in turn might be associated with greater impairment of 
retinal processing.  Such vascular changes in the retina have been measured in ESRD24. This 
may affect Vernier acuity less than the other acuities because the positions of the extended 
bars of the Vernier stimuli could be perceived accurately despite any tiny scotomata caused 
by local vascular failures. Thus we conclude that present evidence does not support the idea 
that the losses of stereopsis in ESRD found by Chiu et al and in this study reflect changes in 
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the cortical mechanisms of binocular combination. It is also possible that errors in 
oculomotor control may contribute to the stereoscopic losses found here, since it is known 
that vergence error and vergence variability may elevate stereoscopic thresholds in normal 
participants25. However, such errors may not be a complete explanation for stereoblindness in 
the patient group, since image motion analogous to that used in the study of vergence 
variability also impairs Vernier acuity, 26 and this was similar in the stereoblind and 
stereoscopic patient sub-groups. 
The correlation between age and Landolt acuity in both the patient and the control groups is 
predictable from previous work. It is likely that there is a neural as well as an optical 
component in the visual losses associated with ageing. With direct viewing of gratings, 
contrast sensitivity is worse in elderly than in young adults27, the losses rising from about 0.2 
log units at 2 c deg-1 to about 0.5 log units at 16 c deg -1. Burton et al28 later showed that 
when gratings are produced on the retina with a technique (laser interferometry) which by-
passes the eye’s optics, sensitivity in the elderly is about 0.1 log units lower at all spatial 
frequencies tested. They concluded that their data provide evidence for neural as well as 
optical losses with ageing. The possible optical contributions include increasing opacity of 
the lens and cornea as well as a decrease in pupil diameter.  The neural losses are likely to be 
mostly cortical. This Ahmad and Spear29 and Spear et al30 found only minor changes in LGN 
responses in elderly monkeys, whereas V1 cells have lower preferred spatial frequencies and 
reduced contrast sensitivities31. 
The reduced acuities found in the patient group may have some practical consequences.  In 
the patients (but not the controls), both Landolt and Vernier acuity correlated with IADL 
scores, but stereoacuity did not. Nor were IADL scores worse in the stereoblind than in the 
stereoscopic patients (see Table 3). However, the stereoblind patients may well be worse on 
some tasks, such as threading a needle, which are not covered by the IADL questionnaire, 
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though for many tasks, such as shopping or financial management, the ability to resolve fine 
spatial detail may be more important.  It seems likely that many ESRD patients will have 
difficulty in reading small print, as often found on the containers of prescribed drugs, and 
perhaps be more likely to fall than the healthy elderly32. 
Limitations of the study 
We did not fix viewing distances precisely with chin-rest and brow-bar in the visual tests, 
therefore it is likely that there will have been small individual variations. However, there is 
no reason to suppose that viewing distances would have been systematically shorter in one of 
the groups. Rather, any effect would be an increase in random variation in patients and 
controls. A potentially important limitation is that of sample size: the stereoblind and 
stereoscopic patient groups contained 9 and 12 participants respectively. Thus some of the 
trends towards differences (in age, or months on dialysis) or correlations with 
neuropsychological measures which we found might become significant with larger numbers 
of participants. However, this would not affect our main conclusions. Finally, the absence of 
an ophthalmological examination of the participants means that our conclusions must be 
viewed with caution. Such an examination would be an important addition to future studies of 
stereopsis in ESRD. 
Conclusions 
In summary, we have confirmed earlier findings that stereopsis and visual acuity are impaired 
in ESRD, and found that Vernier acuity is also worse.  By comparing patients with matched 
controls, we can rule out years of education, IQ, and general cognitive state as contributing to 
patients’ difficulties on our tests.  More than 40% of the patients were stereoblind, as 
assessed by the Randot Forms test, and those with stereopsis had lower stereoacuity than their 
matched controls. Vernier acuity was similar in the stereoscopic and stereoblind sub-groups, 
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but Landolt C acuity was worse in the stereoblind.  We suggest that the impairments of 
stereopsis in ESRD result from changes in the eye, perhaps retinal as well as optical. In the 
patients, lower Vernier and Landolt acuities correlated with lower IADL scores, suggesting 
that inability to resolve fine detail in ESRD may be affecting the tasks of everyday life. 
Further explorations need to be made, however, our data suggest that visual testing would be 
a useful adjunct to the treatment of ESRD. 
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